Skip to main navigation Skip to search Skip to main content

Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer

Eugen Ruckhäberle*, Thomas Karn, Achim Rody, Lars Hanker, Regine Gätje, Dirk Metzler, Uwe Holtrich, Manfred Kaufmann

*Corresponding author for this work

Abstract

Purpose: Sphingolipids are bioactive lipids implicated in apoptosis, cell survival and proliferation. We analyzed the prognostic value of enzymes from sphingolipid metabolism in breast cancer. Methods: Differences in expression of ceramide galactosyl transferase (UGT8), ceramide kinase (CERK), and Ganglioside GD3-Synthase (ST8SIA1) in breast cancer cells were investigated by using microarray data of 1,581 tumor samples. Results: UGT8, CERK, and ST8SIA1 were associated with poor pathohistological grading (P < 0.001). High CERK expression was correlated with ErbB2 status (P = 0.006). Among ER positive breast cancers a significant worse prognosis for patients with tumors showing low ST8SIA1 and UGT8 expression was observed. In the ER negative subgroup those samples with high CERK expression displayed a worse prognosis. In a multivariate analysis only ST8SIA1 and tumor size remained significant. Conclusions: Our experiments reveal that expression of enzymes from the sphingolipid metabolism has prognostic implications in breast cancer.

Original languageEnglish
JournalJournal of Cancer Research and Clinical Oncology
Volume135
Issue number8
Pages (from-to)1005-1013
Number of pages9
ISSN0171-5216
DOIs
Publication statusPublished - 08.2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer'. Together they form a unique fingerprint.

Cite this